Effects of annual influenza vaccination on mortality in patients with heart failure.
Identifieur interne : 000152 ( Main/Exploration ); précédent : 000151; suivant : 000153Effects of annual influenza vaccination on mortality in patients with heart failure.
Auteurs : Vendula Blaya-Nováková ; Francisco J. Prado-Galbarro [Espagne] ; Antonio Sarría-Santamera [Espagne]Source :
- European journal of public health [ 1464-360X ] ; 2016.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Cause de décès (MeSH), Défaillance cardiaque (mortalité), Défaillance cardiaque (étiologie), Espagne (MeSH), Femelle (MeSH), Grippe humaine (complications), Grippe humaine (prévention et contrôle), Humains (MeSH), Modèles des risques proportionnels (MeSH), Mâle (MeSH), Saisons (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Vaccination (statistiques et données numériques), Vaccins antigrippaux (usage thérapeutique), Études de cohortes (MeSH).
- MESH :
- mortalité : Défaillance cardiaque.
- prévention et contrôle : Grippe humaine.
- statistiques et données numériques : Vaccination.
- usage thérapeutique : Grippe humaine, Vaccins antigrippaux.
- étiologie : Défaillance cardiaque.
- Adulte, Adulte d'âge moyen, Cause de décès, Espagne, Femelle, Humains, Modèles des risques proportionnels, Mâle, Saisons, Sujet âgé, Sujet âgé de 80 ans ou plus, Études de cohortes.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Cause of Death (MeSH), Cohort Studies (MeSH), Female (MeSH), Heart Failure (etiology), Heart Failure (mortality), Humans (MeSH), Influenza Vaccines (therapeutic use), Influenza, Human (complications), Influenza, Human (prevention & control), Male (MeSH), Middle Aged (MeSH), Proportional Hazards Models (MeSH), Seasons (MeSH), Spain (MeSH), Vaccination (statistics & numerical data).
- MESH :
- chemical , therapeutic use : Influenza Vaccines.
- complications : Influenza, Human.
- etiology : Heart Failure.
- mortality : Heart Failure.
- prevention & control : Influenza, Human.
- statistics & numerical data : Vaccination.
- Adult, Aged, Aged, 80 and over, Cause of Death, Cohort Studies, Female, Humans, Male, Middle Aged, Proportional Hazards Models, Seasons, Spain.
Abstract
The objective was to evaluate the effect of influenza vaccine on all-cause mortality in a cohort of patients with heart failure followed up in primary care centres of the Community of Madrid, Spain, during the period 2006-10. Results of the Cox proportional-hazard model were adjusted for age and sex and, after 1:1 nearest neighbour matching, for propensity score. The analysis was further stratified by season. Having received annual influenza vaccine was associated with a decreased risk of death during the influenza season (hazard ratio = 0.59, 95% CI = 0.41-0.84), but no protective effect was observed before or after the influenza season.
DOI: 10.1093/eurpub/ckw141
PubMed: 27615735
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effects of annual influenza vaccination on mortality in patients with heart failure.</title><author><name sortKey="Blaya Novakova, Vendula" sort="Blaya Novakova, Vendula" uniqKey="Blaya Novakova V" first="Vendula" last="Blaya-Nováková">Vendula Blaya-Nováková</name><affiliation><nlm:affiliation>Agency for Health Technology Assessment, Institute of Health Carlos III, Madrid, Spain vendula.novakova@salud.madrid.org.</nlm:affiliation><wicri:noCountry code="subField">Spain vendula.novakova@salud.madrid.org.</wicri:noCountry></affiliation></author><author><name sortKey="Prado Galbarro, Francisco J" sort="Prado Galbarro, Francisco J" uniqKey="Prado Galbarro F" first="Francisco J" last="Prado-Galbarro">Francisco J. Prado-Galbarro</name><affiliation wicri:level="3"><nlm:affiliation>Agency for Health Technology Assessment, Institute of Health Carlos III, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Agency for Health Technology Assessment, Institute of Health Carlos III, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Sarria Santamera, Antonio" sort="Sarria Santamera, Antonio" uniqKey="Sarria Santamera A" first="Antonio" last="Sarría-Santamera">Antonio Sarría-Santamera</name><affiliation wicri:level="3"><nlm:affiliation>Agency for Health Technology Assessment, Institute of Health Carlos III, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Agency for Health Technology Assessment, Institute of Health Carlos III, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Medical and Social Sciences, University of Alcalá, Alcalá de Henares, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Surgery, Medical and Social Sciences, University of Alcalá, Alcalá de Henares</wicri:regionArea><wicri:noRegion>Alcalá de Henares</wicri:noRegion></affiliation><affiliation wicri:level="3"><nlm:affiliation>Health Services Research on Chronic Patients Network REDISSEC, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Health Services Research on Chronic Patients Network REDISSEC, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27615735</idno><idno type="pmid">27615735</idno><idno type="doi">10.1093/eurpub/ckw141</idno><idno type="wicri:Area/Main/Corpus">00120</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00120</idno><idno type="wicri:Area/Main/Curation">000120</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000120</idno><idno type="wicri:Area/Main/Exploration">000120</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Effects of annual influenza vaccination on mortality in patients with heart failure.</title><author><name sortKey="Blaya Novakova, Vendula" sort="Blaya Novakova, Vendula" uniqKey="Blaya Novakova V" first="Vendula" last="Blaya-Nováková">Vendula Blaya-Nováková</name><affiliation><nlm:affiliation>Agency for Health Technology Assessment, Institute of Health Carlos III, Madrid, Spain vendula.novakova@salud.madrid.org.</nlm:affiliation><wicri:noCountry code="subField">Spain vendula.novakova@salud.madrid.org.</wicri:noCountry></affiliation></author><author><name sortKey="Prado Galbarro, Francisco J" sort="Prado Galbarro, Francisco J" uniqKey="Prado Galbarro F" first="Francisco J" last="Prado-Galbarro">Francisco J. Prado-Galbarro</name><affiliation wicri:level="3"><nlm:affiliation>Agency for Health Technology Assessment, Institute of Health Carlos III, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Agency for Health Technology Assessment, Institute of Health Carlos III, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Sarria Santamera, Antonio" sort="Sarria Santamera, Antonio" uniqKey="Sarria Santamera A" first="Antonio" last="Sarría-Santamera">Antonio Sarría-Santamera</name><affiliation wicri:level="3"><nlm:affiliation>Agency for Health Technology Assessment, Institute of Health Carlos III, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Agency for Health Technology Assessment, Institute of Health Carlos III, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Medical and Social Sciences, University of Alcalá, Alcalá de Henares, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Surgery, Medical and Social Sciences, University of Alcalá, Alcalá de Henares</wicri:regionArea><wicri:noRegion>Alcalá de Henares</wicri:noRegion></affiliation><affiliation wicri:level="3"><nlm:affiliation>Health Services Research on Chronic Patients Network REDISSEC, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Health Services Research on Chronic Patients Network REDISSEC, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author></analytic><series><title level="j">European journal of public health</title><idno type="eISSN">1464-360X</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Cause of Death (MeSH)</term><term>Cohort Studies (MeSH)</term><term>Female (MeSH)</term><term>Heart Failure (etiology)</term><term>Heart Failure (mortality)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (therapeutic use)</term><term>Influenza, Human (complications)</term><term>Influenza, Human (prevention & control)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Proportional Hazards Models (MeSH)</term><term>Seasons (MeSH)</term><term>Spain (MeSH)</term><term>Vaccination (statistics & numerical data)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Cause de décès (MeSH)</term><term>Défaillance cardiaque (mortalité)</term><term>Défaillance cardiaque (étiologie)</term><term>Espagne (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (complications)</term><term>Grippe humaine (prévention et contrôle)</term><term>Humains (MeSH)</term><term>Modèles des risques proportionnels (MeSH)</term><term>Mâle (MeSH)</term><term>Saisons (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Vaccination (statistiques et données numériques)</term><term>Vaccins antigrippaux (usage thérapeutique)</term><term>Études de cohortes (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Heart Failure</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Heart Failure</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Défaillance cardiaque</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Grippe humaine</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Défaillance cardiaque</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Cause of Death</term><term>Cohort Studies</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Proportional Hazards Models</term><term>Seasons</term><term>Spain</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Cause de décès</term><term>Espagne</term><term>Femelle</term><term>Humains</term><term>Modèles des risques proportionnels</term><term>Mâle</term><term>Saisons</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études de cohortes</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective was to evaluate the effect of influenza vaccine on all-cause mortality in a cohort of patients with heart failure followed up in primary care centres of the Community of Madrid, Spain, during the period 2006-10. Results of the Cox proportional-hazard model were adjusted for age and sex and, after 1:1 nearest neighbour matching, for propensity score. The analysis was further stratified by season. Having received annual influenza vaccine was associated with a decreased risk of death during the influenza season (hazard ratio = 0.59, 95% CI = 0.41-0.84), but no protective effect was observed before or after the influenza season.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27615735</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1464-360X</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>10</Month></PubDate></JournalIssue><Title>European journal of public health</Title><ISOAbbreviation>Eur J Public Health</ISOAbbreviation></Journal><ArticleTitle>Effects of annual influenza vaccination on mortality in patients with heart failure.</ArticleTitle><Pagination><MedlinePgn>890-892</MedlinePgn></Pagination><Abstract><AbstractText>The objective was to evaluate the effect of influenza vaccine on all-cause mortality in a cohort of patients with heart failure followed up in primary care centres of the Community of Madrid, Spain, during the period 2006-10. Results of the Cox proportional-hazard model were adjusted for age and sex and, after 1:1 nearest neighbour matching, for propensity score. The analysis was further stratified by season. Having received annual influenza vaccine was associated with a decreased risk of death during the influenza season (hazard ratio = 0.59, 95% CI = 0.41-0.84), but no protective effect was observed before or after the influenza season.</AbstractText><CopyrightInformation>© The Author 2016. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blaya-Nováková</LastName><ForeName>Vendula</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Agency for Health Technology Assessment, Institute of Health Carlos III, Madrid, Spain vendula.novakova@salud.madrid.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prado-Galbarro</LastName><ForeName>Francisco J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Agency for Health Technology Assessment, Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarría-Santamera</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Agency for Health Technology Assessment, Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Medical and Social Sciences, University of Alcalá, Alcalá de Henares, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Services Research on Chronic Patients Network REDISSEC, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Public Health</MedlineTA><NlmUniqueID>9204966</NlmUniqueID><ISSNLinking>1101-1262</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="Y">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="Y">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27615735</ArticleId><ArticleId IdType="pii">ckw141</ArticleId><ArticleId IdType="doi">10.1093/eurpub/ckw141</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Communauté de Madrid</li></region><settlement><li>Madrid</li></settlement></list><tree><noCountry><name sortKey="Blaya Novakova, Vendula" sort="Blaya Novakova, Vendula" uniqKey="Blaya Novakova V" first="Vendula" last="Blaya-Nováková">Vendula Blaya-Nováková</name></noCountry><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Prado Galbarro, Francisco J" sort="Prado Galbarro, Francisco J" uniqKey="Prado Galbarro F" first="Francisco J" last="Prado-Galbarro">Francisco J. Prado-Galbarro</name></region><name sortKey="Sarria Santamera, Antonio" sort="Sarria Santamera, Antonio" uniqKey="Sarria Santamera A" first="Antonio" last="Sarría-Santamera">Antonio Sarría-Santamera</name><name sortKey="Sarria Santamera, Antonio" sort="Sarria Santamera, Antonio" uniqKey="Sarria Santamera A" first="Antonio" last="Sarría-Santamera">Antonio Sarría-Santamera</name><name sortKey="Sarria Santamera, Antonio" sort="Sarria Santamera, Antonio" uniqKey="Sarria Santamera A" first="Antonio" last="Sarría-Santamera">Antonio Sarría-Santamera</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000152 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000152 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27615735
|texte= Effects of annual influenza vaccination on mortality in patients with heart failure.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27615735" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |